ROYAL BANK OF CANADA - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 53 filers reported holding SPRING BK PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$2,000
-33.3%
2,000
-8.3%
0.00%
Q4 2019$3,000
-57.1%
2,1800.0%0.00%
Q3 2019$7,000
-12.5%
2,1800.0%0.00%
Q2 2019$8,000
-65.2%
2,180
-0.1%
0.00%
Q1 2019$23,000
-4.2%
2,182
-3.1%
0.00%
Q4 2018$24,000
-20.0%
2,251
-10.2%
0.00%
Q3 2018$30,000
+15.4%
2,507
+14.2%
0.00%
Q2 2018$26,000
-23.5%
2,196
+0.7%
0.00%
Q1 2018$34,000
+17.2%
2,180
-1.3%
0.00%
Q4 2017$29,000
+866.7%
2,208
+1119.9%
0.00%
Q3 2017$3,000
+50.0%
181
+0.6%
0.00%
Q2 2017$2,0001800.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
BVF INC/IL 1,301,701$4,803,0000.52%
SECTORAL ASSET MANAGEMENT INC 276,656$1,021,0000.12%
PARSONS CAPITAL MANAGEMENT INC/RI 277,263$1,023,0000.11%
CAXTON CORP 23,821$88,0000.10%
TIEDEMANN ADVISORS, LLC 412,049$1,522,0000.08%
Private Capital Advisors, Inc. 52,335$193,0000.06%
Pegasus Asset Management, Inc. 18,750$69,0000.05%
Hikari Power Ltd 61,336$226,0000.02%
Lee Financial Co 18,750$69,0000.02%
Baker Brothers Advisors 613,144$2,263,0000.02%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders